Guided Liver Elastography for Australia
We provide advanced elastography systems with real-time 2D imaging, enabling more accurate, reliable liver assessments — even in challenging patients. The FibroScan alternative built for Australian clinicians.
Demos, pricing questions, or a quick enquiry — same form. We'll reply within one business day.
Why Elastography Australia
Three reasons clinicians choose guided elastography
Guided, Not Blind
Real-time 2D ultrasound imaging guides every measurement. See exactly where you're measuring, ensuring accurate positioning and reliable results.
vs. blind point-and-shootCompetitive capital
Indicative device pricing is typically significantly lower than comparable new FibroScan capital, with a single-probe workflow that avoids XL add-ons and simplifies total cost.
vs. new FibroScanBuilt for Australia
Optimised for higher BMI patients and MAFLD prevalence. Designed to address the unique healthcare challenges facing Australian clinicians.
Obesity-optimisedThe Clear Choice
iLivTouch vs. Traditional Elastography
See how guided elastography compares to blind point-and-shoot devices
For Every Practice
Designed for how you work
Whether you're a GP screening patients or a specialist monitoring fibrosis, Elastography Australia integrates seamlessly into your workflow.
GP Practices
Screen patients for liver disease without referral delays. Integrate liver health assessment into routine checkups and chronic disease management.
- Immediate results in-clinic
- No referral wait times
- Revenue diversification
- Enhanced patient care
Gastroenterologists
Enhance your hepatology workflow with precise, guided measurements. Monitor fibrosis progression and treatment response with confidence.
- Superior accuracy in difficult cases
- Integrated clinical workflow
- Comprehensive reporting
- Patient monitoring tools
Imaging Centres
Add high-demand liver elastography to your service offering. Efficient throughput with reliable results for referring physicians.
- High patient throughput
- Quick training curve
- Physician-ready reports
- Competitive edge
Return on Investment
Pay off in months, not years
Capital outlay for guided systems is typically significantly lower than comparable new FibroScan deployments, while Medicare-eligible ultrasound-adjunct workflows can improve patient gap economics. That combination supports a strong ROI story for many practices.
Evidence & Trust
Validated by science, trusted by clinicians
Regulatory Status
Meeting the highest standards for medical device safety and efficacy.
510(k) cleared for liver stiffness measurement
European conformity for medical devices
Australian registration in progress
Ready to transform liver assessment in your practice?
Join leading Australian clinicians who have already made the switch to guided liver elastography. Reach out for a demo, a pricing conversation, or any question — we're here to help.